Dan Ziegler

Top papers

• Diabetic Neuropathy: A Position Statement by the American Diabetes Association

  Rodica Pop‐Busui, Andrew J.M. Boulton, Eva L. Feldman, et al.·2016·Diabetes Care
  ↗ 2,427OA
• Diabetic Neuropathies

  Andrew J.M. Boulton, A Vinik, Joseph C. Arezzo, et al.·2005·Diabetes Care
  ↗ 1,824
• Diabetic Cardiovascular Autonomic Neuropathy

  Aaron I. Vinik, Dan Ziegler·2007·Circulation
  ↗ 1,232OA
• Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

  Vincenza Spallone, Dan Ziegler, Roy Freeman, et al.·2011·Diabetes/Metabolism Research and Reviews
  ↗ 943OA
• Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study

  Oana‐Patricia Zaharia, Klaus Straßburger, Alexander Strom, et al.·2019·The Lancet Diabetes & Endocrinology
  ↗ 579
• Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus

  M. Backonja, Nadine Attal, Ralf Baron, et al.·2013·Pain
  ↗ 555
• Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis

  Dan Ziegler, H. Nowak, Péter Kempler, et al.·2004·Diabetic Medicine
  ↗ 542
• Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy

  Dan Ziegler, Ametov As, А Н Баринов, et al.·2006·Diabetes Care
  ↗ 541OA
• Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant ?-lipoic acid

  Dan Ziegler, M Hanefeld, K. J. Ruhnau, et al.·1995·Diabetologia
  ↗ 523OA
• Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

  Giuseppe Lauria, Mayienne Bakkers, Christoph Schmitz, et al.·2010·Journal of the Peripheral Nervous System
  ↗ 505
• Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

  Angelika Bierhaus, Thomas Fleming, Stoyan Stoyanov, et al.·2012·Nature Medicine
  ↗ 490
• Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

  Dan Ziegler, M Hanefeld, K. J. Ruhnau, et al.·1999·Diabetes Care
  ↗ 428